Prostate screening for men with inherited risk of developing aggressive prostate cancer: The PATROL study.

被引：0
|
作者：
Cheng, Heather H.
Follmer, Kristin
de la Calle, Claire Marie
Holcomb, Chenee
Lee, Daniel
Liss, Michael A.
Maxwell, Kara Noelle
Newcomb, Lisa F.
Nyame, Yaw A.
Psutka, Sarah P.
Sokolova, Alexandra
Wolff, Erika
Wright, Jonathan L.
Lin, Daniel W.
机构：
[1] Univ Washington, Div Hematol & Oncol, Seattle, WA USA
[2] Fred Hutchinson Canc Ctr, Seattle, WA USA
[3] Univ Washington, Seattle, WA USA
[4] Univ Penn, Abramson Canc Ctr, Philadelphia, PA USA
[5] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX USA
[6] Univ Penn, Philadelphia, PA USA
[7] Univ Washington, Med Ctr, Seattle, WA USA
[8] Univ Washington, Fred Hutchinson Canc Ctr, Seattle, WA USA
[9] OHSU Knight Canc Inst, Portland, OR USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 4_SUPPL期
关键词：
613-3262-2408; 613-135-4642-282-153-212-218; 3282-4644-9905-10858; 283-183-180; 613-4678-416-12297; 613-545; 3282-415; 6; 4; 2; 38092-25779; 38092-18853; 1;
D O I：
10.1200/JCO.2024.42.4_suppl.TPS357
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：TPS357 / TPS357
页数：1
相关论文
共 50 条
  • [31] Serum cholesterol and prostate cancer risk in the Finnish randomized study of screening for prostate cancer
    Murtola, Teemu J.
    Kasurinen, Tatu V. J.
    Taiaia, Kirsi
    Taari, Kimmo
    Tammela, Teuvo L. J.
    Auvinen, Anssi
    PROSTATE CANCER AND PROSTATIC DISEASES, 2019, 22 (01) : 66 - 76
  • [32] Serum cholesterol and prostate cancer risk in the Finnish randomized study of screening for prostate cancer
    Teemu J. Murtola
    Tatu V. J. Kasurinen
    Kirsi Talala
    Kimmo Taari
    Teuvo L. J. Tammela
    Anssi Auvinen
    Prostate Cancer and Prostatic Diseases, 2019, 22 : 66 - 76
  • [33] Antiepileptic drugs and prostate cancer risk in the Finnish Randomized Study of Screening for Prostate Cancer
    Salminen, Jukka K.
    Kuoppamaki, Viivu
    Talala, Kirsi
    Taari, Kimmo
    Makinen, Jussi
    Peltola, Jukka
    Tammela, Teuvo L. J.
    Auvinen, Anssi
    Murtola, Teemu J.
    INTERNATIONAL JOURNAL OF CANCER, 2021, 149 (02) : 307 - 315
  • [34] Black men in the UK have an elevated risk of developing prostate cancer
    Nature Clinical Practice Urology, 2008, 5 (12): : 640 - 640
  • [35] Toremifene is well tolerated in men at high risk of developing prostate cancer
    Steiner, M
    Boger, R
    Barnette, G
    Mitchell, J
    Price, D
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2004, 13 (11) : 1940S - 1940S
  • [36] Prostate specific antigen dynamics and prostate cancer risk: A population-based study.
    Hird, Amanda Elizabeth
    Saskin, Refik
    Del Giudice, Lisa
    Kulkarni, Girish S.
    Nam, Robert
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [37] Substantial Family History of Prostate Cancer in Black Men Recruited for Prostate Cancer Screening Results From the Prostate Cancer Risk Assessment Program
    Mastalski, Kathleen
    Coups, Elliot J.
    Ruth, Karen
    Raysor, Susan
    Giri, Veda N.
    CANCER, 2008, 113 (09) : 2559 - 2564
  • [38] Predictors of prostate and colorectal cancer screening adherence among men registered for prostate cancer screening
    Red, S.
    Davis, K. M.
    Schwartz, M. D.
    Williams, R. M.
    Ahaghotu, C.
    Taylor, K. L.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2008, 17 (02) : 464 - 464
  • [39] New Drug Option for Men with Aggressive Prostate Cancer
    Printz, Carrie
    CANCER, 2018, 124 (19) : 3797 - 3797
  • [40] Updates in Prostate Cancer Research and Screening in Men at Genetically Higher Risk
    Bancroft, Elizabeth K.
    Ni Raghallaigh, Holly
    Page, Elizabeth C.
    Eeles, Rosalind A.
    CURRENT GENETIC MEDICINE REPORTS, 2021, 9 (04) : 47 - 58
12345